| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/03/2011 | CA2782218A1 Antibody fc mutants with ablated effector functions |
| 06/03/2011 | CA2782163A1 Ondansetron orally disintegrating tablet compositions for prevention of nausea and vomiting |
| 06/03/2011 | CA2782056A1 Mucosal delivery of peptides |
| 06/03/2011 | CA2781887A1 Compositions and methods for the diagnosis and treatment of tumor |
| 06/03/2011 | CA2781318A1 Brain tumor targeting peptides and methods |
| 06/03/2011 | CA2781229A1 Use of an oleogel containing triterpene for healing wounds |
| 06/03/2011 | CA2781082A1 Acrylic or methacrylic polymer including alpha-tocopherol grafts |
| 06/03/2011 | CA2779353A1 Acceleration of wound healing by a tissue inhibitor of metalloproteinases (timp) linked to glycosylphosphatidylinositol (gpi)-anchors |
| 06/03/2011 | CA2777015A1 Film coating agent for solid preparation, and solid preparation using same |
| 06/03/2011 | CA2776471A1 Surfactant-free, water-free, foamable compositions and breakable foams and their uses |
| 06/02/2011 | US20110130698 Pressure-sensitive adhesive agent for skin, pressure-sensitive adhesive sheet for skin, and face plate of ostomy appliance |
| 06/02/2011 | US20110130580 Use of buckysome or carbon nanotube for drug delivery |
| 06/02/2011 | US20110130473 Dilute filtration sterilization process for viscoelastic biopolymers |
| 06/02/2011 | US20110130472 Proteose peptone fraction |
| 06/02/2011 | US20110130461 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
| 06/02/2011 | US20110130446 Injectable taxane pharmaceutical composition |
| 06/02/2011 | US20110130330 Topical Drug Delivery Using Phosphatidylcholine |
| 06/02/2011 | US20110129539 Oral pharmaceutical formulation in the form of an aqueous suspension of microcapsules for modified release of amoxicillin |
| 06/02/2011 | US20110129528 Sustained-release chitosan capsules comprising chitosan and phytic acid |
| 06/02/2011 | US20110129525 Mucosal membrane receptor and uses thereof |
| 06/02/2011 | US20110129510 Fibrous surface structure containing active ingredients with controlled release of active ingredients, use thereof and method for the production thereof |
| 06/02/2011 | US20110129506 Colouring using pearlescent pigments in the food and pharmaceutical sectors |
| 06/02/2011 | US20110129464 Humanized anti-erbb2 antibodies and treatment with anti-erbb2 antibodies |
| 06/02/2011 | US20110129435 Hydrogen peroxide-based skin disinfectant |
| 06/02/2011 | US20110129413 Bioconjugation of Calcium Phosphosilicate Nanoparticles For Selective Targeting of Cells In Vivo |
| 06/01/2011 | EP2327985A2 T1R Hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 06/01/2011 | EP2327784A2 Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
| 06/01/2011 | EP2327777A1 Method for immobilising biologically active substances on polymer carriers (variants) and conjugates produced by said method |
| 06/01/2011 | EP2327775A2 Therapy for alpha-galactosidase a deficiency |
| 06/01/2011 | EP2327724A2 Modified human growth hormone polypeptides and their uses |
| 06/01/2011 | EP2327424A1 Novel excipient for mannitol tableting |
| 06/01/2011 | EP2327421A1 Stabilized liquid anti-RSV antibody formulations |
| 06/01/2011 | EP2327419A1 Microneedle device, and method for enhancing the efficacy of influenza vaccine by using microneedle devive |
| 06/01/2011 | EP2327406A1 Stabilized pharmaceutical composition |
| 06/01/2011 | EP2326351A1 Conjugates of small-interfering nucleic acids |
| 06/01/2011 | EP2326350A2 Methods for killing psma-expressing, taxane-resistant cancer cells |
| 06/01/2011 | EP2326349A1 Novel reagents and method for conjugating biological molecules |
| 06/01/2011 | EP2326348A1 Active particles for bio-analytical applications and methods for preparation thereof |
| 06/01/2011 | EP2326345A2 Human notch3 based fusion proteins as decoy inhibitors of notch3 signaling |
| 06/01/2011 | EP2326331A1 Novel lipid nanoparticles and novel components for delivery of nucleic acids |
| 06/01/2011 | EP2326314A1 Particle compositions with a pre-selected cell internalization mode |
| 06/01/2011 | EP2326306A1 Liquid formulations of bendamustine |
| 06/01/2011 | EP2326304A2 Methods for enhancing the stability of polyorthoesters and their formulations |
| 06/01/2011 | EP2326302A1 Hyaluronic acid-based gels including anesthetic agents |
| 06/01/2011 | EP1259265B1 Nucleic acid formulations for gene delivery |
| 06/01/2011 | DE10203923B4 Verfahren zur Erhöhung der Wasserlöslichkeit lipophiler Wirkstoffe, Herstellung von hochkonzentrierten wässrigen Zusammensetzungen dieser Wirkstoffe, derartige Produkte und ihre Verwendung A method for increasing the water solubility of lipophilic active ingredients, preparation of highly concentrated aqueous compositions of these active ingredients such products and their use |
| 06/01/2011 | CN1927201B Antibiotic compound recipe comprising piperacillin |
| 06/01/2011 | CN1876177B Biodegradable material microsphere blood vessel suppository containing liposome cell factor and its preparation and uses |
| 06/01/2011 | CN102083972A Polycationic gene carriers formed of endogenous amino group-bearing monomers |
| 06/01/2011 | CN102083469A Complex comprising both heparin binding proteins and heparin-hydroxyalkyl starch conjugates |
| 06/01/2011 | CN102083468A Polymer paclitaxel conjugates and methods for treating cancer |
| 06/01/2011 | CN102083467A Solid dispersion, pharmaceutical compositions containing the same, and processes for the production of both |
| 06/01/2011 | CN102083459A Low viscosity compositions comprising a PEGylated GLA-domain containing protein |
| 06/01/2011 | CN102083446A Biological markers and response to treatment for pain, inflammation, neuronal or vascular injury and methods of use |
| 06/01/2011 | CN102083435A Telaprevir dosing regimen |
| 06/01/2011 | CN102083428A Methods of treatment employing prolonged continuous infusion of Belinostat |
| 06/01/2011 | CN102083420A Pharmaceutical dosage form comprising polymeric carrier composition |
| 06/01/2011 | CN102083419A Pharmaceutical composition containing surface-coated microparticles |
| 06/01/2011 | CN102083414A Composition comprising an antibiotic and a corticosteroid |
| 06/01/2011 | CN102083413A Method and composition for treating ocular hypertension and glaucoma |
| 06/01/2011 | CN102083411A Carrier |
| 06/01/2011 | CN102083410A Pharmaceutical formulation for the production of rapidly disintegrating tablets |
| 06/01/2011 | CN102079821A Compositions comprising superhydrophilic amphiphilic copolymers and methods of use thereof |
| 06/01/2011 | CN102079790A Recombination fusion protein PACAP-PTD (Pituitary Adenylate Cyclase Activating Peptide-Protein Transduction Domain) as well as expression method and application thereof |
| 06/01/2011 | CN102078637A Sodium alginate/tamarind gum blended drug-loaded membrane as well as preparation method and application thereof |
| 06/01/2011 | CN102078620A Pharmaceutical composition comprising a strontium salt, vitamine d and a cyclodextrine |
| 06/01/2011 | CN102078619A Transdermal therapeutic preparation |
| 06/01/2011 | CN102078618A Medicine carrier comprising nanowires with porous structure |
| 06/01/2011 | CN102078617A Method for synthesizing mesoporous silica-based nanocomposite embedded with gold nanorods |
| 06/01/2011 | CN102078613A Inhibitors of her3 activity |
| 06/01/2011 | CN102078612A Nasal in-situ gel containing mometasone furoate and H1 receptor antagonist |
| 06/01/2011 | CN102078608A Formulation of human antibodies for treating tnf-alpha associated disorders |
| 06/01/2011 | CN102078604A Meningococcus capsular polysaccharide polyvalent multivalent conjugate vaccine, preparation method and application thereof |
| 06/01/2011 | CN102078596A Application of toad peptide antibiotics in preparing drugs for treating hemorrhoids |
| 06/01/2011 | CN102078595A Application of toad peptide antibiotic for preparing medicines for curing tinea manus and pedis |
| 06/01/2011 | CN102078594A Application of toad peptide antibiotics in preparing drugs for treating anal fistula |
| 06/01/2011 | CN102078593A Application of toad peptide antibiotic for preparing medicines for curing diabetic foot |
| 06/01/2011 | CN102078592A Application of toad peptide antibiotics in preparing drugs for treating acnes |
| 06/01/2011 | CN102078483A Chinese patent medicine (Bezoar Qianliekang Turunda) for treating prostate disease and preparation method thereof |
| 06/01/2011 | CN102078474A Nano-dispersible tablet for four-season common cold and preparation method thereof |
| 06/01/2011 | CN102078442A Wind expelling and itching relieving granule with improved taste |
| 06/01/2011 | CN102078359A Heterophylly falsestarwort root dispersing tablet |
| 06/01/2011 | CN102078350A Dispersing tablet of total saponins of Chinese thorowax root |
| 06/01/2011 | CN102078349A Cyclodextrin inclusion compound containing angelica volatile oil |
| 06/01/2011 | CN102078325A Nasal composition containing povidone iodine and cyclodextrin inclusion of glucocorticoid |
| 06/01/2011 | CN102078323A Minodronate-containing pharmaceutical composition |
| 06/01/2011 | CN102078320A Iloperidone pharmaceutical composition and preparation method thereof |
| 06/01/2011 | CN102078317A Dihydroartemisinine-phospholipid complex and preparation and application thereof |
| 06/01/2011 | CN102078312A Curcumin compound dry powder inhaler as well as preparation method and application thereof |
| 06/01/2011 | CN102078310A Generally linear effervescent oral fentanyl dosage form and methods of administering |
| 06/01/2011 | CN102078307A Medicine composition of dronedarone hydrochloride solid dispersion and preparation method thereof |
| 06/01/2011 | CN102078306A Taxol nanoparticle freeze-drying preparation containing recombinant human serum albumin |
| 06/01/2011 | CN102078305A 苯达莫司汀冻干药物组合物 Bendamustine lyophilized pharmaceutical composition |
| 06/01/2011 | CN102078304A Insulin drug carried microspheres and preparation method thereof |
| 06/01/2011 | CN102078303A Preparation method of freeze-dried idamycin hydrochloride preparation |
| 06/01/2011 | CN102078302A Method for preparing berbamine chitosan-agar nano particles |
| 06/01/2011 | CN102078301A Taxotere nano preparation carried by albumin and phospholipid and method preparing same |
| 06/01/2011 | CN102078300A Solid preparation of Torasemide liposome |
| 06/01/2011 | CN102078298A Lansoprazole liposome combined medicament as well as preparation method and applications thereof |
| 06/01/2011 | CN102078296A Reserpine fructose injection and preparation method thereof |